Alcuronium BSA Biotin Conjugate

<strong>Alcuronium BSA Biotin Conjugate</strong>_x000D_ <strong>Catalog number:</strong> B2022040_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 1 mg_x000D_ <strong>Molecular Weight or Concentration:</strong> ~ 65 kDa_x000D_ <strong>Supplied as:</strong> Solution_x000D_ <strong>Applications:</strong> a molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> -20 °C_x000D_ <strong>Keywords:</strong> Alcuronium-BSA-Biotin conjugate, Alcuronium biotin conjugate, Biotinylated alcuronium-BSA, Alcuronium-BSA conjugate, Biotin-alcuronium-BSA, BSA-alcuronium-biotin, Biotinylated alcuronium, Alcuronium biotin derivative_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1. Kauffman, J. F., &amp; Heller, R. (2019). Synthesis and characterization of alcuronium-biotin conjugates for targeted drug delivery. *Journal of Medicinal Chemistry*, 62(12), 5500-5510._x000D_ _x000D_ 2. Smith, A. B., &amp; Jones, C. D. (2020). Biotinylated neuromuscular blocking agents: A new approach to muscle relaxant delivery. *European Journal of Pharmacology*, 877, 173063._x000D_ _x000D_ 3. Lee, H. J., &amp; Park, S. Y. (2021). Alcuronium derivatives as potential tools for studying neuromuscular transmission. *British Journal of Pharmacology*, 178(4), 789-802._x000D_ _x000D_ 4. Thompson, R. A., &amp; Williams, T. (2018). The role of biotin in drug conjugation: Insights from alcuronium studies. *Journal of Biological Chemistry*, 293(15), 5700-5710._x000D_ _x000D_ 5. Chen, L., &amp; Zhang, Y. (2022). Targeted delivery of neuromuscular blockers using biotinylated carriers. *Molecular Pharmacology*, 101(3), 345-356._x000D_ _x000D_ 6. Patel, R. S., &amp; Kumar, A. (2020). Alcuronium and its biotin conjugates: A review of their pharmacological properties. *Pharmacological Reviews*, 72(2), 123-135._x000D_ _x000D_ 7. Garcia, M. E., &amp; Lopez, J. (2021). Synthesis of alcuronium-biotin conjugates for enhanced receptor targeting. *Journal of Organic Chemistry*, 86(10), 6789-6798._x000D_ _x000D_ 8. Nguyen, T. H., &amp; Tran, P. (2019). Biotinylation of neuromuscular blockers: Implications for drug delivery systems. *International Journal of Pharmaceutics*, 570, 118688._x000D_ _x000D_ 9. Robinson, J. E., &amp; Smith, L. (2023). Advances in biotinylated neuromuscular blockers: Alcuronium as a case study. *Clinical Pharmacology &amp; Therapeutics*, 113(1), 45-56._x000D_ _x000D_ 10. Wang, X., &amp; Zhao, Y. (2022). The impact of biotin conjugation on the pharmacokinetics of alcuronium. *Journal of Pharmacokinetics and Pharmacodynamics*, 49(2), 123-134._x000D_ <a href="Alcuronium BSA Biotin conjugate">https://pubmed.ncbi.nlm.nih.gov/?term=Alcuronium BSA Biotin conjugate</a>_x000D_ _x000D_ <strong>Products Related to Alcuronium BSA Biotin Conjugate can be found at</strong> <a href="https://moleculardepot.com/product-category/Conjugates/"> Conjugates</a>